CA Stock MarketDetailed Quotes

MEND Nurosene Health Inc

Watchlist
  • 0.000
  • 0.0000.00%
15min DelayMarket Closed Dec 20 09:30 ET
0Market Cap0.00P/E (TTM)

Nurosene Health Inc Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Sep 30, 2022
(Q4)Sep 30, 2022
(Q3)Jun 30, 2022
(Q2)Mar 31, 2022
(Q1)Dec 31, 2021
(FY)Sep 30, 2021
(Q4)Sep 30, 2021
(Q3)Jun 30, 2021
(Q2)Mar 31, 2021
(Q1)Dec 31, 2020
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-83.51%-4.78M
38.81%-137.45K
19.54%-772.54K
-38.25%-1.43M
-586.78%-2.44M
-1,631.42%-2.6M
-224.64K
-960.16K
-1.04M
-354.74K
Net income from continuing operations
-164.49%-13.45M
-166.12%-7.21M
63.89%-857.39K
-244.01%-2.47M
-1,119.92%-2.9M
-1,638.45%-5.08M
---2.71M
---2.37M
---719.1K
---238.1K
Depreciation and amortization
--596.91K
----
----
----
----
--0
----
----
----
----
Asset impairment expenditure
--5.76M
----
----
----
----
--0
----
----
----
----
Remuneration paid in stock
3.10%1.25M
-76.82%184.67K
-176.88%-317.17K
7,258.68%669.93K
1,243.18%709.25K
12,832.21%1.21M
--796.62K
--412.55K
--9.1K
--52.8K
Deferred tax
---248.12K
----
----
----
----
--0
----
----
----
----
Other non cashItems
-53.97%609.23K
-81.47%159.23K
-100.00%-1
--1
3,114.29%450K
1,040.03%1.32M
--859.41K
--464K
--0
--14K
Change In working capital
1,448.41%701.06K
-25.48%618.02K
-25.23%402.02K
214.18%371.94K
-276.64%-690.92K
-412.34%-51.99K
--829.32K
--537.65K
---325.76K
---183.44K
-Change in receivables
129.60%94.04K
590.59%297.09K
73.32%-68.6K
14.59%-122K
82.31%-12.45K
-959.70%-317.68K
---60.56K
---257.12K
---142.84K
---70.39K
-Change in inventory
----
----
--0
----
----
----
----
---61.8K
----
----
-Change in prepaid assets
375.76%138.39K
95.20%-5.72K
-26.52%50.73K
-53.66%55.15K
146.26%38.23K
47.92%-50.19K
---119.23K
--69.04K
--119.01K
---82.64K
-Change in payables and accrued expense
41.07%445.6K
169.26%326.65K
-72.78%214.37K
159.27%468.79K
-259.94%-564.2K
120.90%315.87K
---471.66K
--787.53K
--180.81K
--352.77K
-Change in other working capital
--23.03K
--0
--175.52K
--0
60.20%-152.49K
----
----
----
---420.94K
---383.19K
Cash from discontinued investing activities
Operating cash flow
-83.51%-4.78M
38.81%-137.45K
19.54%-772.54K
-38.25%-1.43M
-586.78%-2.44M
-1,631.42%-2.6M
---224.64K
---960.16K
---1.04M
---354.74K
Investing cash flow
Cash flow from continuing investing activities
-34.96%-2.19M
911
90.70%-131.9K
0
-2.06M
-1.62M
-1.42M
Net intangibles purchas and sale
90.36%-152.49K
--0
----
----
----
---1.58M
----
---1.42M
----
----
Net business purchase and sale
---2.07M
---13.49K
---2
--0
---2.06M
--0
----
--0
----
----
Net investment purchase and sale
187.50%35K
--14.4K
----
----
----
---40K
----
--0
----
----
Cash from discontinued investing activities
Investing cash flow
-34.96%-2.19M
--911
90.70%-131.9K
--0
---2.06M
---1.62M
----
---1.42M
----
----
Financing cash flow
Cash flow from continuing financing activities
-92.02%691.58K
-65.96%30.68K
-93.65%544.4K
3K
-75.83%113.49K
334.85%8.67M
90.13K
8.58M
0
469.56K
Net issuance payments of debt
----
----
----
----
----
----
----
--0
----
----
Net common stock issuance
-93.37%575.09K
-122.10%-19.92K
-94.42%478.51K
--3K
-75.83%113.49K
334.85%8.67M
--90.13K
--8.58M
--0
--469.56K
Proceeds from stock option exercised by employees
--116.49K
---1
----
----
----
--0
----
--0
----
----
Cash from discontinued financing activities
Financing cash flow
-92.02%691.58K
-65.96%30.68K
-93.65%544.4K
--3K
-75.83%113.49K
334.85%8.67M
--90.13K
--8.58M
--0
--469.56K
Net cash flow
Beginning cash position
241.05%6.29M
-98.56%115.95K
-74.18%475.98K
-2.71%1.9M
241.05%6.29M
--1.84M
--8.04M
--1.84M
--1.96M
--1.84M
Current changes in cash
-241.26%-6.28M
93.97%-105.86K
-105.81%-360.03K
-37.96%-1.43M
-3,915.57%-4.38M
141.05%4.44M
---1.76M
--6.2M
---1.04M
--114.83K
End cash Position
-99.84%10.09K
-99.84%10.09K
-98.56%115.95K
-48.39%475.98K
-2.71%1.9M
241.05%6.29M
--6.29M
--8.04M
--922.26K
--1.96M
Free cash from
-17.79%-4.93M
92.39%-137.45K
61.12%-925.03K
-38.25%-1.43M
-586.78%-2.44M
-2,683.62%-4.19M
---1.81M
---2.38M
---1.04M
---354.74K
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Sep 30, 2022(Q4)Sep 30, 2022(Q3)Jun 30, 2022(Q2)Mar 31, 2022(Q1)Dec 31, 2021(FY)Sep 30, 2021(Q4)Sep 30, 2021(Q3)Jun 30, 2021(Q2)Mar 31, 2021(Q1)Dec 31, 2020
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -83.51%-4.78M38.81%-137.45K19.54%-772.54K-38.25%-1.43M-586.78%-2.44M-1,631.42%-2.6M-224.64K-960.16K-1.04M-354.74K
Net income from continuing operations -164.49%-13.45M-166.12%-7.21M63.89%-857.39K-244.01%-2.47M-1,119.92%-2.9M-1,638.45%-5.08M---2.71M---2.37M---719.1K---238.1K
Depreciation and amortization --596.91K------------------0----------------
Asset impairment expenditure --5.76M------------------0----------------
Remuneration paid in stock 3.10%1.25M-76.82%184.67K-176.88%-317.17K7,258.68%669.93K1,243.18%709.25K12,832.21%1.21M--796.62K--412.55K--9.1K--52.8K
Deferred tax ---248.12K------------------0----------------
Other non cashItems -53.97%609.23K-81.47%159.23K-100.00%-1--13,114.29%450K1,040.03%1.32M--859.41K--464K--0--14K
Change In working capital 1,448.41%701.06K-25.48%618.02K-25.23%402.02K214.18%371.94K-276.64%-690.92K-412.34%-51.99K--829.32K--537.65K---325.76K---183.44K
-Change in receivables 129.60%94.04K590.59%297.09K73.32%-68.6K14.59%-122K82.31%-12.45K-959.70%-317.68K---60.56K---257.12K---142.84K---70.39K
-Change in inventory ----------0-------------------61.8K--------
-Change in prepaid assets 375.76%138.39K95.20%-5.72K-26.52%50.73K-53.66%55.15K146.26%38.23K47.92%-50.19K---119.23K--69.04K--119.01K---82.64K
-Change in payables and accrued expense 41.07%445.6K169.26%326.65K-72.78%214.37K159.27%468.79K-259.94%-564.2K120.90%315.87K---471.66K--787.53K--180.81K--352.77K
-Change in other working capital --23.03K--0--175.52K--060.20%-152.49K---------------420.94K---383.19K
Cash from discontinued investing activities
Operating cash flow -83.51%-4.78M38.81%-137.45K19.54%-772.54K-38.25%-1.43M-586.78%-2.44M-1,631.42%-2.6M---224.64K---960.16K---1.04M---354.74K
Investing cash flow
Cash flow from continuing investing activities -34.96%-2.19M91190.70%-131.9K0-2.06M-1.62M-1.42M
Net intangibles purchas and sale 90.36%-152.49K--0---------------1.58M-------1.42M--------
Net business purchase and sale ---2.07M---13.49K---2--0---2.06M--0------0--------
Net investment purchase and sale 187.50%35K--14.4K---------------40K------0--------
Cash from discontinued investing activities
Investing cash flow -34.96%-2.19M--91190.70%-131.9K--0---2.06M---1.62M-------1.42M--------
Financing cash flow
Cash flow from continuing financing activities -92.02%691.58K-65.96%30.68K-93.65%544.4K3K-75.83%113.49K334.85%8.67M90.13K8.58M0469.56K
Net issuance payments of debt ------------------------------0--------
Net common stock issuance -93.37%575.09K-122.10%-19.92K-94.42%478.51K--3K-75.83%113.49K334.85%8.67M--90.13K--8.58M--0--469.56K
Proceeds from stock option exercised by employees --116.49K---1--------------0------0--------
Cash from discontinued financing activities
Financing cash flow -92.02%691.58K-65.96%30.68K-93.65%544.4K--3K-75.83%113.49K334.85%8.67M--90.13K--8.58M--0--469.56K
Net cash flow
Beginning cash position 241.05%6.29M-98.56%115.95K-74.18%475.98K-2.71%1.9M241.05%6.29M--1.84M--8.04M--1.84M--1.96M--1.84M
Current changes in cash -241.26%-6.28M93.97%-105.86K-105.81%-360.03K-37.96%-1.43M-3,915.57%-4.38M141.05%4.44M---1.76M--6.2M---1.04M--114.83K
End cash Position -99.84%10.09K-99.84%10.09K-98.56%115.95K-48.39%475.98K-2.71%1.9M241.05%6.29M--6.29M--8.04M--922.26K--1.96M
Free cash from -17.79%-4.93M92.39%-137.45K61.12%-925.03K-38.25%-1.43M-586.78%-2.44M-2,683.62%-4.19M---1.81M---2.38M---1.04M---354.74K
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Trending CA Stocks
Dividend Kings of Canada Dividend Kings of Canada

Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility. Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility.